Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective study - Colao, A; Auriemma, R S; Galdiero, M (J Clin Endocrinol Metab, 2009)
et al.